Who owns Vera Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of VERA from SEC Form 13F filings across 225 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 225 institutions disclosed 84.9M shares of Vera Therapeutics, Inc. worth $2.72B — about 117.7% of shares outstanding; the largest disclosed holder is Deep Track Capital, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
225
13F holders
$2.72B
value, 2026 filers
117.7%
of shares outstanding (84.9M sh)
42
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of VERA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Deep Track Capital, LP | 7.0M | $226.0M | 3.7% | 9.7% | +75.0% |
| 2 | BlackRock, Inc. | 5.7M | $185.0M | 0.0% | 7.9% | -0.3% |
| 3 | Avoro Capital Advisors LLC | 5.6M | $182.0M | 1.9% | 7.8% | -1.6% |
| 4 | DEERFIELD MANAGEMENT COMPANY, L.P. | 4.3M | $140.1M | 2.2% | 6% | +10.8% |
| 5 | STATE STREET CORP | 3.3M | $106.6M | 0.0% | 4.6% | -20.4% |
| 6 | Kynam Capital Management, LP | 3.0M | $96.9M | 5.4% | 4.2% | +3.8% |
| 7 | Sofinnova Investments, Inc. | 2.8M | $90.2M | 3.9% | 3.9% | 0.0% |
| 8 | FMR LLC | 2.8M | $90.2M | 0.0% | 3.9% | +0.7% |
| 9 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.8M | $88.8M | 0.0% | 3.8% | -31.4% |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 2.7M | $87.5M | 0.0% | 3.8% | -1.6% |
| 11 | Eversept Partners, LP | 2.4M | $76.3M | 4.1% | 3.3% | +6.7% |
| 12 | DEUTSCHE BANK AG\ | 2.1M | $68.8M | 0.0% | 3% | +93.4% |
| 13 | First Light Asset Management, LLCNEW | 2.0M | $63.3M | 3.8% | 2.7% | new |
| 14 | FRONTIER CAPITAL MANAGEMENT CO LLC | 1.9M | $61.0M | 0.7% | 2.6% | +45.8% |
| 15 | Pictet Asset Management Holding SA | 1.8M | $59.4M | 0.1% | 2.6% | +47.2% |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | 1.7M | $56.3M | 0.0% | 2.4% | +2.9% |
| 17 | BRAIDWELL LP | 1.7M | $55.8M | 2.3% | 2.4% | +205.8% |
| 18 | ALLIANCEBERNSTEIN L.P. | 1.7M | $53.7M | 0.0% | 2.3% | +4.5% |
| 19 | Integral Health Asset Management, LLC | 1.5M | $32.3M | 2.0% | 2.1% | -14.3% |
| 20 | GOLDMAN SACHS GROUP INC | 1.4M | $45.9M | 0.0% | 2% | +2.9% |
| 21 | Woodline Partners LP | 1.0M | $32.4M | 0.1% | 1.4% | +0.1% |
| 22 | BANK OF AMERICA CORP /DE/ | 952,693 | $30.8M | 0.0% | 1.3% | +61.4% |
| 23 | AMERICAN CENTURY COMPANIES INC | 952,095 | $30.7M | 0.0% | 1.3% | +9.9% |
| 24 | SCHRODER INVESTMENT MANAGEMENT GROUP | 864,269 | $28.0M | 0.0% | 1.2% | +69.2% |
| 25 | MILLENNIUM MANAGEMENT LLC | 838,290 | $27.1M | 0.0% | 1.2% | +200.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.